1. Home
  2. HOTH vs AMS Comparison

HOTH vs AMS Comparison

Compare HOTH & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • AMS
  • Stock Information
  • Founded
  • HOTH 2017
  • AMS 1980
  • Country
  • HOTH United States
  • AMS United States
  • Employees
  • HOTH N/A
  • AMS N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • AMS Medical Specialities
  • Sector
  • HOTH Health Care
  • AMS Health Care
  • Exchange
  • HOTH Nasdaq
  • AMS Nasdaq
  • Market Cap
  • HOTH 15.6M
  • AMS 17.2M
  • IPO Year
  • HOTH 2019
  • AMS N/A
  • Fundamental
  • Price
  • HOTH $1.29
  • AMS $2.45
  • Analyst Decision
  • HOTH Strong Buy
  • AMS
  • Analyst Count
  • HOTH 3
  • AMS 0
  • Target Price
  • HOTH $4.00
  • AMS N/A
  • AVG Volume (30 Days)
  • HOTH 230.9K
  • AMS 4.0K
  • Earning Date
  • HOTH 08-12-2025
  • AMS 08-13-2025
  • Dividend Yield
  • HOTH N/A
  • AMS N/A
  • EPS Growth
  • HOTH N/A
  • AMS N/A
  • EPS
  • HOTH N/A
  • AMS N/A
  • Revenue
  • HOTH N/A
  • AMS $29,251,000.00
  • Revenue This Year
  • HOTH N/A
  • AMS $5.06
  • Revenue Next Year
  • HOTH N/A
  • AMS N/A
  • P/E Ratio
  • HOTH N/A
  • AMS N/A
  • Revenue Growth
  • HOTH N/A
  • AMS 26.61
  • 52 Week Low
  • HOTH $0.65
  • AMS $2.27
  • 52 Week High
  • HOTH $3.80
  • AMS $4.60
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 50.80
  • AMS 45.80
  • Support Level
  • HOTH $1.22
  • AMS $2.40
  • Resistance Level
  • HOTH $1.31
  • AMS $2.70
  • Average True Range (ATR)
  • HOTH 0.08
  • AMS 0.10
  • MACD
  • HOTH -0.00
  • AMS -0.02
  • Stochastic Oscillator
  • HOTH 57.69
  • AMS 17.35

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About AMS American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.

Share on Social Networks: